UNSPSC 85682910: Replacement of right sphenoid bone with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of right sphenoid bone with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0NRC3KZ

UNSPSC 85682910 "Replacement of right sphenoid bone with nonautologous tissue substitute, percutaneous approach" is a Commodity code that shows little relevant recent activity under state and local procurement. The code nominally describes a specialized orthopedic surgical procedure, but recent state and local opportunities tagged to this code do not involve sphenoid bone replacement or related orthopedic implant procurement. Instead, the opportunities span occupational health surveillance, pharmacy benefit management, independent medical evaluation services for pension disability determinations, surgical center-of-excellence carve-out programs, temporary health professional staffing, and emergency medical services for youth in custody — none of which align with the code's stated scope. The mismatch suggests either tagging error in the source data or drift in how this code is applied at the state and local level. Without opportunities actually soliciting sphenoid bone implants, orthopedic devices, or related surgical materials, the code presents no clear procurement signal for vendors in the orthopedic implant or surgical device space.

The recent opportunities across this code span multiple issuing bodies — the City of Phoenix Retirement Office (Arizona), the City of Long Beach (California), the Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), the Collier County Board of County Commissioners (Florida), and the County of Santa Clara Health System (California) — reflecting fragmented, health-system-wide contracting activity unrelated to the code's nominal scope. Geographic activity appears concentrated in Arizona, California, Florida, Texas, and Washington, but the concentration reflects general health-system and benefits procurement rather than orthopedic device sourcing. Vendors evaluating pursuit under this code should verify tagging accuracy with issuing bodies before investing in proposal development, as the current opportunity mix does not support targeted positioning in sphenoid bone replacement, orthopedic implants, or surgical tissue substitutes.